CRISPR Therapeutics AG (CRSP) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2026-06-09

CRISPR Therapeutics AG (CRSP) has filed 14 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-06-09. 2 Form 8-K material event filings were reported by CRSP in the last 90 days. InsiderAlpha tracks every CRSP SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About CRISPR Therapeutics AG (CRSP)

SIC classification	Biological Products, (No Diagnostic Substances) (SIC 2836)
SEC CIK	0001674416

90-Day SEC Filing Activity

Form 4 filings (90d)	14
Form 8-K filings (90d)	2
Latest Form 4 filing	2026-06-09

Recent CRSP Insider Transactions (Form 4)

Date	Insider	Role	Transaction	Shares	Price	Value	Filing
2026-05-29	Patel Naimish	Chief Medical Officer	S — Open-market sale	3.8K	$55.62	$211K	SEC
2026-05-28	Patel Naimish	Chief Medical Officer	M — Option exercise	10.0K	—	—	SEC
2026-03-23	Kulkarni Samarth	Chief Executive Officer	S — Open-market sale	10.0K	$46.78	$469K	SEC
2026-03-23	Prasad Raju	Chief Financial Officer	S — Open-market sale	3.7K	$46.78	$173K	SEC
2026-03-23	KASINGER JAMES R.	General Counsel and Secretary	S — Open-market sale	3.2K	$46.78	$149K	SEC
2026-03-20	Kulkarni Samarth	Chief Executive Officer	M — Option exercise	19.7K	—	—	SEC
2026-03-20	KASINGER JAMES R.	General Counsel and Secretary	M — Option exercise	6.2K	—	—	SEC
2026-03-20	Prasad Raju	Chief Financial Officer	M — Option exercise	6.2K	—	—	SEC
2026-03-16	KASINGER JAMES R.	General Counsel and Secretary	S — Open-market sale	3.5K	$48.26	$166K	SEC
2026-03-16	Kulkarni Samarth	Chief Executive Officer	S — Open-market sale	10.3K	$48.26	$499K	SEC
2026-03-16	Prasad Raju	Chief Financial Officer	S — Open-market sale	5.8K	$48.26	$282K	SEC
2026-03-16	Prasad Raju	Chief Financial Officer	S — Open-market sale	4.0K	$48.26	$194K	SEC
2026-03-16	Patel Naimish	Chief Medical Officer	S — Open-market sale	3.1K	$48.26	$152K	SEC
2026-03-16	Prasad Raju	Chief Financial Officer	G — Bona-fide gift	750	$0.00	—	SEC
2026-03-14	Prasad Raju	Chief Financial Officer	M — Option exercise	10.0K	—	—	SEC

All transactions sourced from SEC EDGAR Form 4 filings for CRISPR Therapeutics AG (CRSP). Updated in real time as new filings are submitted to the SEC.

Most-Active CRSP Insiders — Last 90 Days

Insider	Form 4 filings	Total transaction value
Patel Naimish	4	$211K
KASINGER JAMES R.	1	—
Prasad Raju	1	—
Mahatme Sandesh	1	—
Behbahani Ali	1	—

Recent CRSP Form 8-K Material Events

2026-06-04 — Item 5.02, 5.03, 5.07, 9.01 [SEC]
2026-05-04 — Item 2.02, 9.01 [SEC]
2026-03-16 — Item 1.01, 2.03, 3.02, 9.01 · Financing · neutral [SEC]
CRISPR Therapeutics completed a private offering of $600 million in convertible senior notes due 2031, with net proceeds of approximately $585.2 million after fees. The notes carry a 1.7308% coupon (adjusted for Swiss withholding tax) and are convertible into common shares, with
2026-03-11 — Item 8.01, 9.01 · Financing · positive [SEC]
CRISPR Therapeutics announced a private offering of convertible senior notes due 2031, initially sized at $350 million and subsequently upsized to $550 million aggregate principal amount. The offering was priced on March 11, 2026, and marketed to qualified institutional buyers un

Recent Insider Filings

2026-06-09 — George Simeon (Insider)
2026-06-09 — Behbahani Ali (Insider)
2026-06-09 — Fardis Maria (Insider)
2026-06-09 — Fleming Harold Edward (Insider)
2026-06-09 — Greene John (Insider)

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in CRSP insider filings:

P	Open-market purchase by the insider
S	Open-market sale by the insider
A	Grant, award, or other acquisition from the issuer
M	Exercise or conversion of derivative security (e.g. options)
F	Payment of exercise price or tax liability via share withholding
G	Bona-fide gift of securities
D	Disposition to the issuer (e.g. share buyback participation)
J	Other acquisition or disposition
X	Exercise of in-the-money or at-the-money derivative security
C	Conversion of derivative security
V	Transaction voluntarily reported earlier than required

CRSP Insider Trading — FAQ

What is the latest insider trade for CRSP?: CRISPR Therapeutics AG (CRSP) had 14 insider filings in the last 90 days, with the most recent on 2026-06-09. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying CRSP stock?: 0 insider purchases of CRSP were filed in the last 90 days.
How many insiders are selling CRSP stock?: 0 insider sales of CRSP were filed in the last 90 days.
Where can I see CRSP SEC filings (Form 4, 10-K, 10-Q, 8-K)?: InsiderAlpha aggregates every CRSP SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Related Companies — Recent Insider Activity

Learn More

Open the live CRSP dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.